Home/Filings/4/0000950170-23-071936
4//SEC Filing

Berman Mark A. 4

Accession 0000950170-23-071936

CIK 0001832415other

Filed

Dec 19, 7:00 PM ET

Accepted

Dec 20, 5:10 PM ET

Size

5.0 KB

Accession

0000950170-23-071936

Insider Transaction Report

Form 4
Period: 2023-12-18
Berman Mark A.
Chief Medical Officer
Transactions
  • Award

    Common Stock

    2023-12-18+25,362448,140 total
Footnotes (2)
  • [F1]The Reporting person was awarded 25,362 Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs shall vest on June 1, 2024.
  • [F2]Includes 34,587 shares acquired under the Issuer's 2021 Employee Stock Purchase Plan on November 30, 2023.

Documents

1 file

Issuer

Better Therapeutics, Inc.

CIK 0001832415

Entity typeother

Related Parties

1
  • filerCIK 0001890348

Filing Metadata

Form type
4
Filed
Dec 19, 7:00 PM ET
Accepted
Dec 20, 5:10 PM ET
Size
5.0 KB